Twenty of the largest pharmaceutical companies, ranked by how much of their first-half 2026 revenue came from a single molecule. The range runs from 76.8% to 5.6%, one drug appears twice at wildly different weights, and two companies changed their largest product within the year.
Mylan presented on Viatris at the 38th Annual J.P. Morgan Healthcare Conference. Below are selected slides from the presentations of Mylan and Teva at the conference and figures comparing the existing business entities prior to the merger with Upjohn.